Phase 1 study combining elotuzumab with autologous stem cell transplant and lenalidomide for multiple myeloma.
Coffey DG, Osman K, Aleman A, Bekri S, Kats S, Dhadwal A, Catamero D, Kim-Schulze S, Gnjatic S, Chari A, Parekh S, Jagannath S, Cho HJ.
Coffey DG, et al. Among authors: parekh s.
J Immunother Cancer. 2024 Apr 12;12(4):e008110. doi: 10.1136/jitc-2023-008110.
J Immunother Cancer. 2024.
PMID: 38609316
Free PMC article.
Clinical Trial.